Last reviewed · How we verify
commercially available live vaccine BCG — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
commercially available live vaccine BCG (commercially available live vaccine BCG) — Serum Life Science Europe GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| commercially available live vaccine BCG TARGET | commercially available live vaccine BCG | Serum Life Science Europe GmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- commercially available live vaccine BCG CI watch — RSS
- commercially available live vaccine BCG CI watch — Atom
- commercially available live vaccine BCG CI watch — JSON
- commercially available live vaccine BCG alone — RSS
Cite this brief
Drug Landscape (2026). commercially available live vaccine BCG — Competitive Intelligence Brief. https://druglandscape.com/ci/commercially-available-live-vaccine-bcg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab